CAREDX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
CAREDX, INC. (CDNA) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 473.75 thousand shares for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-04-30.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2025-04-30
- CAREDX, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2025-03-31 was 473.75K shares, a 82.56% decline year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2024-12-31 was 143.30K shares, a 74.71% decline year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2024-09-30 was 222.78K shares, a 39.67% increase year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2024-06-30 was 644.13K shares, a 68.42% decline year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2024 was 3.73M shares, a 7.50% decline from fiscal 2023.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2023 was 4.03M shares, a 68.04% increase from fiscal 2022.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2022 was 2.40M shares, a 106.68% increase from fiscal 2021.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2021 was 1.16M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|---|---|---|
| 2025-03-31 | 473.75K shares 10-Q · filed 2025-04-30 | 617.06K shares derived: sum of 2 quarters · filed 2025-04-30 | 839.83K shares derived: sum of 3 quarters · filed 2025-04-30 | 1.48M shares derived: sum of 4 quarters · filed 2025-04-30 |
| 2024-12-31 | 143.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 366.08K shares derived: sum of 2 quarters · filed 2025-02-28 | 1.01M shares derived: sum of 3 quarters · filed 2025-02-28 | 3.73M shares 10-K · filed 2025-02-28 |
| 2024-09-30 | 222.78K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | 866.90K shares derived: sum of 2 quarters · filed 2024-11-04 | 3.58M shares 10-Q · filed 2024-11-04 | 4.15M shares derived: sum of 4 quarters · filed 2024-11-04 |
| 2024-06-30 | 644.13K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | 3.36M shares 10-Q · filed 2024-07-31 | 3.93M shares derived: sum of 3 quarters · filed 2024-07-31 | 4.09M shares derived: sum of 4 quarters · filed 2024-07-31 |
| 2024-03-31 | 2.72M shares 10-Q · filed 2024-05-09 | 3.28M shares derived: sum of 2 quarters · filed 2024-05-09 | 3.44M shares derived: sum of 3 quarters · filed 2024-05-09 | 5.48M shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 566.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 726.25K shares derived: sum of 2 quarters · filed 2024-02-28 | 2.77M shares derived: sum of 3 quarters · filed 2024-02-28 | 4.03M shares 10-K · filed 2024-02-28 |
| 2023-09-30 | 159.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 2.20M shares derived: sum of 2 quarters · filed 2023-11-08 | 3.46M shares 10-Q · filed 2023-11-08 | 3.80M shares derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | 2.04M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 3.30M shares 10-Q · filed 2023-08-08 | 3.64M shares derived: sum of 3 quarters · filed 2023-08-08 | 4.48M shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 1.26M shares 10-Q · filed 2023-05-10 | 1.60M shares derived: sum of 2 quarters · filed 2023-05-10 | 2.44M shares derived: sum of 3 quarters · filed 2023-05-10 | 3.19M shares derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | 340.47K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | 1.17M shares derived: sum of 2 quarters · filed 2023-02-27 | 1.92M shares derived: sum of 3 quarters · filed 2023-02-27 | 2.40M shares 10-K · filed 2023-02-27 |
| 2022-09-30 | 832.99K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 1.58M shares derived: sum of 2 quarters · filed 2022-11-03 | 2.06M shares 10-Q · filed 2022-11-03 | 2.42M shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 749.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 1.22M shares 10-Q · filed 2022-08-04 | 1.59M shares derived: sum of 3 quarters · filed 2022-08-04 | 1.76M shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 474.00K shares 10-Q · filed 2022-05-05 | 836.66K shares derived: sum of 2 quarters · filed 2022-05-05 | 1.01M shares derived: sum of 3 quarters · filed 2022-05-05 | 1.39M shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 362.66K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 536.21K shares derived: sum of 2 quarters · filed 2022-02-24 | 913.57K shares derived: sum of 3 quarters · filed 2022-02-24 | 1.16M shares 10-K · filed 2022-02-24 |
| 2021-09-30 | 173.55K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | 550.91K shares derived: sum of 2 quarters · filed 2021-10-28 | 797.29K shares 10-Q · filed 2021-10-28 | |
| 2021-06-30 | 377.36K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | 623.74K shares 10-Q · filed 2021-07-29 | ||
| 2021-03-31 | 246.38K shares 10-Q · filed 2021-05-05 | |||
| 2020-09-30 | 287.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | 814.02K shares derived: sum of 2 quarters · filed 2020-10-29 | 1.11M shares 10-Q · filed 2020-10-29 | |
| 2020-06-30 | 526.72K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 821.20K shares 10-Q · filed 2020-08-04 | ||
| 2020-03-31 | 294.48K shares 10-Q · filed 2020-04-30 | |||
| 2019-09-30 | 1.22M shares 10-Q · filed 2019-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |